Page 4 - Nasdaq Cbio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Court Denies JDS1’s Motion for Expedited Proceedings Board Reiterates Commitment to Distributing Cash to Stockholders Once Potential Liability and...

Catalyst Biosciences (NASDAQ:CBIO – Get Rating) and AgeX Therapeutics (NYSE:AGE – Get Rating) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, earnings, risk, dividends, valuation, analyst recommendations and profitability. Institutional & Insider Ownership 62.4% of Catalyst Biosciences shares […]

Shares of Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $0.77 and traded as high as $1.61. Catalyst Biosciences shares last traded at $1.45, with a volume of 2,625,425 shares. The stock’s 50 day simple moving average […]

Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) was the recipient of a significant growth in short interest in May. As of May 31st, there was short interest totalling 2,540,000 shares, a growth of 1,503.5% from the May 15th total of 158,400 shares. Currently, 9.5% of the company’s shares are sold short. Based on an average […]

Analysts predict that Catalyst Biosciences, Inc. (NASDAQ:CBIO – Get Rating) will announce ($0.43) earnings per share (EPS) for the current quarter, Zacks reports. Zero analysts have made estimates for Catalyst Biosciences’ earnings, with estimates ranging from ($0.64) to ($0.22). Catalyst Biosciences posted earnings per share of ($0.64) in the same quarter last year, which would […]